Michael A. Mussallem
December 12, 2022
Edwards Lifesciences Announces CEO Succession Plan
December 12, 2022 —  Edwards Lifesciences Corporation announced that following regular succession planning discussions…
Read More
US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza International Trials Unit located in the Lake Zone of Tanzania with the aim of exploring the burden of arrhythmia in adults with and without HIV.
December 12, 2022
Weill Cornell Medicine partners with Poland-based company Cardiomatics to investigate the relationship between HIV and heart rhythm disorders
December 12, 2022 —  US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza…
Read More
Clinical abstract focuses on value of PURE EP’s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation
December 09, 2022
BioSig’s PURE EP System Highlighted in the Journal of Atrial Fibrillation and Electrophysiology
December 9, 2022 —    BioSig Technologies, Inc.  an advanced digital signal processing technology company delivering…
Read More
Dr. Rami Kahwash, director of Ohio State’s Heart and Vascular Research Organization and a professor of clinical medicine in the Ohio State College of Medicine.
December 09, 2022
Ohio State First in World to Participate in Trial Confirming Efficacy of Novel Heart Failure Treatment
December 9, 2022 —  The Ohio State University Wexner Medical Center is first in the world to randomize a patient in a…
Read More
December 09, 2022
Ninerafaxstat Showcased at the 19th Annual Global Cardio Vascular Clinical Trialists (CVCT) Forum with Focus on the Potential in Non-obstructive Hypertrophic Cardiomyopathy
December 9, 2022 —  Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies…
Read More
Cardiac care should follow the patient on a virtual journey and deliver high-fidelity insights to care providers, eliminating the gaps in data transmission
December 08, 2022
With Minutes Between Life and Death, Continuous Remote ECG Monitoring Saves Lives
December 8, 2022 — Heart disease is the number one killer in the U.S., and high-fidelity monitoring is the beginning of…
Read More
Along with physician leaders and members, the society has helped the subspecialty officially join NRMP’s Medical Specialties Matching Program in 2025
December 08, 2022
SCAI Leads the Way for Interventional Cardiology to Join “The Match”
December 8, 2022 — The Society for Cardiovascular Angiography & Interventions (SCAI), a leading nonprofit medical…
Read More
Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint
December 08, 2022
Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL (bempedoic acid) Meets Primary Endpoint
December 8, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting …
Read More
Jonathan Rothberg, PhD
December 08, 2022
Butterfly Announces CEO Transition
December 8, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body…
Read More
Brian Arends, left, checks the electrical resistivity and conductivity of the wearable heart monitor as Zheng Yan, center, and Yadong Xu, right, observe in Yan's lab. The lab is located in the Roy Blunt NextGen Precision Health building. Pate McCuien/University of Missouri
December 07, 2022
University of Missouri Researchers Design New Heart Health Wearable
December 7, 2022 —  While heart disease is a leading cause of death in the United States, most people can be treated…
Read More
December 07, 2022
Computerized Decision Support System Helps to Reduce Cardiovascular Risk Factors in Patients with Diabetes
December 7, 2022 —  Compared with team-based care alone, the addition of a computerized clinical decision support…
Read More
Allogeneic CardiALLO therapy for heart failure to complement autologous cell therapy currently enrolling in Phase III CardiAMP Heart Failure clinical trial
December 07, 2022
BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure
December 7, 2022 —   BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
December 07, 2022
Ultromics Receives FDA Clearance for AI-based Platform for Echocardiography
December 7, 2022 — Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for…
Read More
Designed to assist physicians detect findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia.
December 05, 2022
Imagen Technologies Announces FDA Clearance of Aorta-CAD
December 5, 2022 —  Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the…
Read More
The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices,
December 05, 2022
Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) Shortage - Letter to Health Care Providers
December 5, 2022 —  The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a…
Read More
December 05, 2022
Top 10 Most-read Content in November
Here is a recap of what DAIC viewers found most interesting during the month of November: 1. Study Finds That Risk of…
Read More
Ms. Nieves, donor family, and doctors. Photo courtesy of Montefiore Health System.
December 02, 2022
World's First HIV-Positive to HIV-Positive Heart Transplant Recipient Meets Donor Family, Shares Gratitude for Life & Advocates for Organ Donation
December 2, 2022 —  Westchester resident, 62-year-old Miriam Nieves, is especially grateful this Thanksgiving season.…
Read More
Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System.
December 02, 2022
Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2 Aortic Valve System
December 2, 2022 —  Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market…
Read More
Last year, U.S. Congressman Andy Barr (KY-06) introduced this legislation in the House to honor the legacy of his wife, Carol Leavell Barr, who passed away tragically from sudden cardiac death brought on by mitral valve prolapse, an underlying heart condition that causes death in .2% of cases.
December 02, 2022
CAROL Act Will Prioritize Research on Heart Valve Disease
December 2, 2022 —  The U.S. Senate today passed the bipartisan Cardiovascular Advances in Research and Opportunities…
Read More
Transverse heart sections from wild type mice (WT) and transgenic mice overexpressing beta-3 adrenergic receptor in cardiomyocytes (c-hB3tg) after 3 months of aortic stenosis (transaortic constriction, TAC) or control (sham). Hypertrophy after TAC was less severe in the transgenic mice. Courtesy of CNIC
December 01, 2022
A New Therapeutic Target for the Prevention of Heart Failure Due to Aortic Stenosis
December 1, 2022 —  Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have identified a new…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now